Monitoring the motion of lung tumours with kilovoltage intrafraction monitoring

Phase 1

• Conditions: ung Cancer; Lung Cancer; Cancer - Lung - Non small cell

• Registration Number: ACTRN12615000726550
• Lead Sponsor: epean and Blue Mountains Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

1. Patient equal to or greater than 18 years of age
2. Patient with NSCLC or SCLC who are assessed as suitable for radical radiotherapy or chemo radiotherapy
3. Tumour greater than or equal to 5mm diameter
4. Tumour suitably positioned for fiducial insertion with linear EBUS
5. Patient does not have medical co-morbidities which preclude EBUS and fiducial insertion.
6. Centrally positioned primary and/or lymph nodes as identified by staging investigations such as CT scan of chest and/or PET scan.
7. Patients with curative intent

Exclusion Criteria

1. Pregnant women and children under the age of 18;
2. Patients unable to give informed consent;
3. Patients with cardiac pacemakers and patients on anticoagulants.

Study & Design

• Study Type: Interventional
• Study Design: Not specified